At present, most authors consider nadir GH levels > 0.3 μg/L or 0.4 μg/L during OGTT sufficient for the diagnosis of acromegaly in patients with elevated IGF-1 (1,4,12-18). This evidence concerns the gene IGF1 and acromegaly.